Healthcare IT Today
JULY 20, 2023
We are particularly excited about the ability of these tools to drive more efficient and faster drug development processes in the biopharma industry.” “The Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development.
Healthcare IT Today
APRIL 11, 2023
The development and manufacturing process for these important new drugs is very different from traditional medicines. This article focuses on the technology that ensures quality in the process, and is based on a conversation with Graziella Piras, PhD, Life Science Business Development Director at 908 Devices.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
JANUARY 8, 2024
Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis. As DCTs and virtual site acceptance accelerates, a knock-on effect will be that more of these trials will include HEOR analysis.
Healthcare IT Today
JULY 25, 2022
Cornerstone is developing highly intelligent, automated software to accurately and efficiently clean and prepare data in a fraction of the time of traditional methods. Its software can significantly accelerate data analysis and healthcare research. The company also announced a $5 million seed round led by Healthy Ventures.
Lloyd Price
FEBRUARY 18, 2024
Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!
Digital Health Global
NOVEMBER 20, 2023
With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. However, they are vital to the drug development and approval process and critical in enabling access to innovative medicines.
Lloyd Price
DECEMBER 8, 2018
Down rounds, where a private company raises money at a price lower than its previous valuation, accounted for 9% of venture financing in the third quarter, according to an analysis by law firm Fenwick & West, while up rounds accounted for 78%. But key facets of its business didn’t develop as planned, say people familiar with the company.
Expert insights. Personalized for you.
66 
Let's personalize your content